Strategy for intention to treat analysis in randomised trials with missing outcome data

Loss to follow-up is often hard to avoid in randomised trials. This article suggests a framework for intention to treat analysis that depends on making plausible assumptions about the missing data and including all participants in sensitivity analyses

[1]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[2]  Sally Hollis,et al.  A graphical sensitivity analysis for clinical trials with non‐ignorable missing binary outcome , 2002, Statistics in medicine.

[3]  Robert O'Neill,et al.  MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets , 2009, Journal of biopharmaceutical statistics.

[4]  V. Agrawal,et al.  Authors’ reply , 2010, Indian journal of psychiatry.

[5]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[6]  J. Ioannidis,et al.  Strengthening the reporting of genetic risk prediction studies: the GRIPS statement , 2011, European Journal of Epidemiology.

[7]  I. White,et al.  Eliciting and using expert opinions about dropout bias in randomized controlled trials , 2007, Clinical trials.

[8]  A. Astrup,et al.  Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study , 2009, The Lancet.

[9]  A. Mackinnon.  Statistical treatment of withdrawal in trials of anti-dementia drugs , 2008, The Lancet.

[10]  R. Little,et al.  The prevention and treatment of missing data in clinical trials. , 2012, The New England journal of medicine.

[11]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.

[12]  Michael G. Kenward,et al.  Missing Data in Clinical Trials - A Practical Guide , 2007 .

[13]  W. Shih,et al.  Current Controlled Trials in Cardiovascular Medicine , 2002 .

[14]  Douglas G Altman,et al.  Missing outcomes in randomized trials: addressing the dilemma , 2009, Open medicine : a peer-reviewed, independent, open-access journal.

[15]  Hideaki Watanabe,et al.  Points to Consider on Missing Data , 2006 .

[16]  P Peduzzi,et al.  Analysis as-randomized and the problem of non-adherence: an example from the Veterans Affairs Randomized Trial of Coronary Artery Bypass Surgery. , 1993, Statistics in medicine.

[17]  Mary Sano,et al.  Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study , 2008, The Lancet.

[18]  Zhang Jing,et al.  Guideline on missing data in confirmatory clinical trials , 2012 .

[19]  J. Ware,et al.  Interpreting incomplete data in studies of diet and weight loss. , 2003, The New England journal of medicine.

[20]  J. Wittes.  Missing Inaction: Preventing Missing Outcome Data in Randomized Clinical Trials , 2009, Journal of biopharmaceutical statistics.